LensGen Closes $21M Series A Funding

LensGen, Inc., an Irvine, Calif.-based developer of modular, fluid-optic accommodating intraocular lens, closed a $21m Series A financing.

The round, which includes an option to expand the financing commitment by an additional $5m, was led by the corporate venture investment arm of HOYA Group and included participation from Relativity Healthcare Partners.

The company is using the funds to continue to develop the lens.

Led by Ramgopal Rao, CEO and Founder, LensGen is advancing Juvene™ accommodating intraocular lens designed to permanently restore clear and continuous vision at all distances for patients with cataracts and presbyopia.
The lens – implanted using current surgical techniques used for traditional intraocular lenses – provides accommodation by mimicking the eye’s natural accommodation process to change shape and adjust focus, like the autofocus of a camera.



Join the discussion